CIK 0001474167 · Non-accelerated filer<br>Smaller reporting company
Cosmos Health Inc.
Sign in to watch- Ticker
- COSM
- Exchange
- Nasdaq
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 270611758
- Phone
- 312-536-3102
- Business address
- 5 AGIOU GEORGIOU, PILEA, THESSALONIKI, Greece, 55438
- Former names
- Cosmos Holdings Inc., PRIME ESTATES & DEVELOPMENTS INC
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- NT 10-Q Other NT 10-Q
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
- S-1/A Offering Registration Statement
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Chief Executive Officer bought 34,004 shares at $0.45 ($15,217)
- 4 Open-market buy Chief Executive Officer bought 141,825 shares at $0.44 ($62,800)
- 4 Open-market buy Chief Executive Officer bought 174,172 shares at $0.47 ($82,000)
- 4 Open-market buy Chief Executive Officer bought 147,563 shares at $0.45 ($65,961)
- 4 Open-market buy Chief Executive Officer bought 79,254 shares at $0.43 ($34,000)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Delisting notice
- 4 Open-market buy Chief Executive Officer bought 254,618 shares at $0.40 ($102,000)
- 4 Open-market buy Chief Executive Officer bought 177,234 shares at $0.40 ($71,000)
Page 5 of 32 · 639 filings